Related Experiment Video
Updated: Jun 10, 2026
06:38
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
Improving the performance of enteric vaccines in the developing world.
Andrew C Serazin1, Laura A Shackelton, Christopher Wilson
1The Global Health Program, The Bill & Melinda Gates Foundation, Seattle, WA, USA. andrew.serazin@gatesfoundation.org
Nature Immunology
|August 20, 2010
Summary
New technologies and diverse scientific disciplines are crucial for developing effective vaccines against enteric pathogens like rotavirus and poliovirus, especially in populations with lower vaccine efficacy. This approach aims for universal solutions to combat enteric diseases globally.
Area of Science:
- Microbiology
- Immunology
- Public Health
Background:
- Existing vaccines for enteric pathogens like rotavirus and poliovirus exhibit reduced efficacy in certain populations.
- Enteric diseases remain a significant global health burden, particularly affecting vulnerable communities.
Framework:
- This research highlights the need for innovative technological and interdisciplinary approaches.
- Focus on developing next-generation vaccines with enhanced immunogenicity and broader applicability.
Implementation:
- Exploring novel vaccine platforms and delivery systems.
- Integrating diverse scientific expertise, including molecular biology, vaccinology, and epidemiology.
- Conducting research in diverse demographic and environmental settings to assess real-world efficacy.
Implications:
- Advancing the development of universally effective vaccines against critical enteric infections.
- Improving global public health outcomes by reducing the incidence and impact of diarrheal diseases.
- Laying the groundwork for future strategies to combat a wider range of infectious diseases.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:51Vaccinations
Overview